颅内血肿微创清除技术与内科保守治疗高血压脑出血的临床疗效

The Clinical Efficacy of Minimally Invasive Removal of Intracranial Hematoma Technology and Conservative Treatment of Hypertensive Cerebral Hemorrhage

目的对比分析颅内血肿微创清除术与内科保守治疗对高血压性脑出血(HICH)的临床治疗效果,旨在为HICH的临床治疗提供参考。方法将86例HICH患者按照随机分组的方法分为观察组(接受颅内血肿微创清术)和对照组(接受内科保守治疗),比较两组治疗总有效率和治疗后第1、7及14天时神经功能缺损程度。结果观察组治疗总有效率高于对照组,且两组比较差异有统计学意义(P<0.05)。两组治疗前神经功能缺损评分比较差异无统计学意义(P>0.05);治疗后第1、7及14天时观察组评分均低于对照组,两组比较差异有统计学意义(P<0.05)。结论颅内血肿微创清除术对于HICH的治疗,能提高治疗总有效率,减少死亡率,改善患者神经功能缺损状况及预后,值得临床推广应用。

Objective A comparative analysis of minimally invasive surgery of intracranial hematoma and conservative treatment for hypertensive intracerebral hemorrhage （ HICH） to provide a reference for the clinical treatment of HICH. Methods 86 cases of HICH patients were randomized into the observation group （ receiving minimally invasive intracranial hematoma dissection ） and the control group （ receiving conservative treatment） , the total efficiency and the degree of neurological deficit after treatment 1 d, 7 d and 14 d were compared. Results The total effective rate of the observation group was higher than that of the control group （P〈0.05）. There was no statistically significant difference of the degree of neurological deficit of the two groups before the treatment （ P〉0.05 ） , while the degree of neurological deficit of the observation group after treatment 1 d, 7 d and 14 d were lower than those of the control group （P〈0.05）. Conclusions Minimally invasive surgery for HICH treatment could improve the total efficiency of treatment and re-duce mortality, improve neurological deficit situation and prognosis, and deserve the clinical expansion.